This finding is in line with published data correlating high IGF-I serum levels to an increased risk of lung malignancy [35–37], as well as colon and breast cancer [38, 39], and showing that patients with lung cancer have significantly increased circulating IGF-I levels compared to healthy controls [40]. The gene discussed is IGF1; the disease is lung cancer.